Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Beyond binary classification: Comparing three region-based multi-phase Aβ staging systems 2025-05-01
  2. Clinical utility of cerebrospinal fluid biomarkers measured by LUMIPULSE® system 2022-11-02
  3. Preparedness of the Brazilian health-care system to provide access to a disease-modifying Alzheimer's disease treatment 2022-09-05

Studies

8 studies carry this tag.

Date range

2005 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 2
  • Annals of clinical and translational neurology 1
  • Current topics in developmental biology 1
  • Journal of medical systems 1
  • Journal of pharmaceutical and biomedical analysis 1

7 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Beyond binary classification: Comparing three region-based multi-phase Aβ staging systems

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-05-01 Biomarkers

    Region-based multi-phase Aβ deposition systems demonstrate practical utility in detecting early pathological changes, understanding disease progression, and informing early diagnosis and intervention strategies for AD.

  2. Clinical utility of cerebrospinal fluid biomarkers measured by LUMIPULSE® system

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Annals of clinical and translational neurology 2022-11-02 Biomarkers

    CSF biomarkers measured with the LUMIPULSE system showed good agreement with amyloid PET imaging.

  3. Preparedness of the Brazilian health-care system to provide access to a disease-modifying Alzheimer's disease treatment

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2022-09-05 Biomarkers

    Brazil has no national dementia strategy or established pathway for evaluation of cognitive concerns, and dementia is typically diagnosed late if at all.

  4. A Systematic Review and Implementation of IoT-Based Pervasive Sensor-Enabled Tracking System for Dementia Patients

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Journal of medical systems 2019-07-17 Cognitive tests and assessment

    In today's world, 46.8 million people suffer from brain related diseases.

  5. Comparative analyses of plasma amyloid-β levels in heterogeneous and monomerized states by interdigitated microelectrode sensor system

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Science advances 2019-04-17 Biomarkers

    Detection of amyloid-β (Aβ) aggregates contributes to the diagnosis of Alzheimer disease (AD).

  6. A novel silanization agent based single used biosensing system: Detection of C-reactive protein as a potential Alzheimer's disease blood biomarker

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Journal of pharmaceutical and biomedical analysis 2018-03-12 Biomarkers

    This paper illustrates a new and sensitive electrochemical immunosensor for the analysis of C-reactive protein.

  7. Activation of the CB2 receptor system reverses amyloid-induced memory deficiency

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurobiology of aging 2012-07-12 Biomarkers

    Cannabinoid type 2 (CB(2)) agonists are neuroprotective and appear to play modulatory roles in neurodegenerative processes in Alzheimer's disease.

  8. The choroid plexus-cerebrospinal fluid system: from development to aging

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Current topics in developmental biology 2005-01-01 Tau biomarkers

    The function of the cerebrospinal fluid (CSF) and the tissue that secretes it, the choroid plexus (CP), has traditionally been thought of as both providing physical protection to the brain through buoyancy and facilitating the removal of brain metabolites through the bulk drainage of CSF.

All topic tags with their study counts